Pricing Log in Create free account

Iterum Therapeutics PLC (ITRMF) vs Kairos Pharma, Ltd. (KAPA)

Iterum Therapeutics PLC and Kairos Pharma, Ltd. are both Biotechnology companies. Iterum Therapeutics PLC and Kairos Pharma, Ltd. are of similar size ($1.6M and $1.5M). Kairos Pharma, Ltd. has the higher net margin (0.00% vs −2,930.5%) and the higher return on invested capital (−322.9% vs −455.5%). Across the 12 metrics below, Iterum Therapeutics PLC leads on 6 and Kairos Pharma, Ltd. on 6.

Valuation

Metric ITRMF KAPA Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B n/m 0.36 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.21 0.66
EV/Sales 24.37 n/m 9.02
Earnings yield 0.00% (399.90%) (32.88%)
Free cash flow yield 0.00% (264.69%) (23.13%)

Profitability

Metric ITRMF KAPA Biotechnology median
Gross margin (81.85%) — 68.51%
Operating margin (2,243.48%) 0.00% 0.00%
Net margin (2,930.54%) 0.00% 0.00%
Free cash flow margin (2,122.61%) 0.00% 0.00%
Return on equity 285.48% (113.96%) (51.96%)
Return on assets (111.35%) (104.32%) (46.06%)
Return on invested capital (455.51%) (322.91%) 0.00%

Growth

Metric ITRMF KAPA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 57.43% (30.44%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ITRMF KAPA Biotechnology median
Debt to equity (2.87) 0.00 0.00
Current ratio 2.13 11.98 4.97
Net debt to EBITDA 0.24 1.65 1.01

Dividend

Metric ITRMF KAPA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ITRMF KAPA Biotechnology median
Market cap 1.59m 1.54m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack